DWRKF logo

Drägerwerk AG & Co. KGaA (DWRKF) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

$'dan işlem gören Drägerwerk AG & Co. KGaA (DWRKF), 0 değerindeki bir Healthcare şirketidir. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 49/100 (ihtiyatlı) olarak derecelendirilmiştir.

Son analiz: 15 Mar 2026
49/100 AI Puanı

Drägerwerk AG & Co. KGaA (DWRKF) Sağlık ve Boru Hattı Genel Bakışı

CEOStefan A. Drager
Çalışanlar15170
MerkezLübeck, DE
Halka Arz Yılı2017
SektörHealthcare

Drägerwerk AG & Co. KGaA, founded in 1889, is a global leader in medical and safety technology, offering a diverse portfolio of products and services ranging from acute care solutions to personal protection equipment, serving both healthcare and industrial sectors with a strong presence in Europe, the Americas, Asia, and Australia.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 15 Mar 2026

Yatırım Tezi

Drägerwerk AG & Co. KGaA presents a compelling investment case based on its established market position and diversified product portfolio. The company's focus on both medical and safety technology provides resilience across economic cycles. Growth catalysts include increasing demand for advanced medical equipment and stringent safety regulations in industrial sectors. The company's P/E ratio of 13.39, as of 2026-03-15, suggests a potentially undervalued opportunity compared to its peers. The company's beta of -0.19 indicates lower volatility than the market, making it a noteworthy option for risk-averse investors. However, investors should monitor the impact of currency fluctuations and raw material costs on profitability.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Drägerwerk AG & Co. KGaA operates in the medical and safety technology sectors, providing a diversified revenue stream.
  • The company's global presence across Europe, the Americas, Africa, Asia, and Australia reduces regional risk.
  • Drägerwerk's product portfolio includes both medical devices and safety equipment, offering resilience to sector-specific downturns.
  • The company's P/E ratio of 13.39 suggests a potentially attractive valuation compared to industry peers.
  • A beta of -0.19 indicates lower volatility compared to the broader market.

Rakipler & Benzerleri

Güçlü Yönler

  • Diversified product portfolio across medical and safety technology.
  • Global presence and distribution network.
  • Strong brand reputation and established market position.
  • Focus on innovation and technological leadership.

Zayıflıklar

  • Exposure to currency fluctuations.
  • Dependence on regulatory approvals.
  • Competition from larger players in certain market segments.
  • Potential for product liability claims.

Katalizörler

  • Upcoming: Potential new product launches in medical devices sector.
  • Ongoing: Increasing demand for safety equipment due to stricter regulations.
  • Ongoing: Expansion into emerging markets with growing healthcare infrastructure.
  • Upcoming: Potential partnerships to expand product offerings.
  • Ongoing: Continued innovation in gas detection technologies.

Riskler

  • Potential: Economic downturns affecting healthcare spending.
  • Potential: Changes in government regulations impacting medical device approvals.
  • Ongoing: Exposure to currency fluctuations.
  • Potential: Increased competition from low-cost manufacturers.
  • Ongoing: Product liability claims.

Büyüme Fırsatları

  • Growth opportunity 1: Expansion in emerging markets represents a significant growth opportunity for Drägerwerk. Increasing healthcare spending and industrialization in regions like Asia-Pacific and Latin America create demand for the company's medical and safety solutions. By tailoring its product offerings and distribution strategies to local needs, Drägerwerk can capture a larger share of these rapidly growing markets. This expansion could contribute to a 10-15% increase in revenue over the next five years.
  • Growth opportunity 2: The increasing adoption of digital health technologies presents an opportunity for Drägerwerk to integrate its medical devices with software platforms and data analytics. By offering connected solutions that improve patient monitoring, enhance clinical decision-making, and streamline healthcare workflows, Drägerwerk can differentiate itself from competitors and capture a larger share of the digital health market. The digital health market is projected to reach $379 billion by 2024.
  • Growth opportunity 3: The growing emphasis on workplace safety and environmental protection drives demand for Drägerwerk's safety equipment and gas detection solutions. Stricter regulations and increased awareness of workplace hazards create opportunities for the company to expand its sales to industries such as oil and gas, mining, and construction. Focusing on innovative gas detection technologies and comprehensive safety training programs can strengthen Drägerwerk's position in this market.
  • Growth opportunity 4: Strategic acquisitions and partnerships can accelerate Drägerwerk's growth by expanding its product portfolio, entering new markets, and gaining access to innovative technologies. By acquiring companies with complementary products or technologies, Drägerwerk can strengthen its competitive position and offer a more comprehensive suite of solutions to its customers. Targeted acquisitions in areas such as remote patient monitoring and industrial safety can drive significant growth.
  • Growth opportunity 5: The increasing demand for home healthcare solutions presents an opportunity for Drägerwerk to develop and market medical devices and monitoring systems for use in the home. As the population ages and healthcare costs rise, there is a growing need for affordable and convenient home healthcare solutions. By offering user-friendly medical devices and remote monitoring services, Drägerwerk can tap into this growing market and improve the quality of life for patients.

Fırsatlar

  • Expansion in emerging markets.
  • Increasing adoption of digital health technologies.
  • Growing emphasis on workplace safety and environmental protection.
  • Strategic acquisitions and partnerships.

Tehditler

  • Economic downturns affecting healthcare spending.
  • Changes in government regulations.
  • Technological disruptions from new entrants.
  • Increased competition from low-cost manufacturers.

Rekabet Avantajları

  • Strong brand reputation and established market position.
  • Diversified product portfolio across medical and safety technology.
  • Global presence and distribution network.
  • Focus on innovation and technological leadership.

DWRKF Hakkında

Drägerwerk AG & Co. KGaA, established in Lübeck, Germany in 1889, has evolved into a prominent player in the medical and safety technology sectors. Initially focused on respiratory and diving equipment, the company expanded its portfolio to include a comprehensive range of products and services for acute point of care, such as emergency care, perioperative care, critical care, and perinatal care. This includes anesthesia devices, ventilators, thermoregulation equipment, patient monitoring systems, and related consumables and accessories. Drägerwerk also caters to the safety needs of various industries and public sectors. Their offerings encompass personal protective equipment, gas detection technology, and integrated hazard management solutions for industries like mining, as well as public services like fire departments and disaster protection agencies. These products include stationary and mobile gas detection systems, alcohol and drug testing devices, and fire training facilities. With a global footprint spanning Europe, the Americas, Africa, Asia, and Australia, Drägerwerk AG & Co. KGaA serves a diverse clientele across healthcare, industrial, and public sectors. The company's commitment to innovation and quality has solidified its position as a trusted provider of critical medical and safety solutions worldwide.

Ne Yaparlar

  • Develops and markets system solutions for acute point of care, including emergency, perioperative, critical, and perinatal care.
  • Provides anesthesia devices and ventilators.
  • Offers thermoregulation equipment, consumables, and accessories.
  • Supplies gas management systems and patient monitoring solutions.
  • Develops and markets personal protective equipment for industrial and public sectors.
  • Offers stationary and mobile gas detection systems.
  • Provides alcohol and drug testing devices.
  • Offers training and services, including fire training facilities.

İş Modeli

  • Develops and manufactures medical and safety technology products.
  • Sells products and services directly to hospitals, industrial clients, and public sector organizations.
  • Generates revenue from product sales, service contracts, and training programs.
  • Focuses on innovation and quality to maintain a competitive advantage.

Sektör Bağlamı

Drägerwerk AG & Co. KGaA operates within the medical devices and safety equipment industries, both experiencing steady growth driven by technological advancements, aging populations, and increasing safety regulations. The medical device market is projected to reach $600 billion by 2025, while the safety equipment market is expected to reach $60 billion. Drägerwerk competes with major players like ARHCF (Arjo), BIESF (B. Braun), and CMPUY (Coloplast), focusing on innovation and specialized solutions to maintain its competitive edge. The company's diversified portfolio allows it to capitalize on growth opportunities in both sectors.

Kilit Müşteriler

  • Hospitals and healthcare providers
  • Industrial companies in sectors such as mining, oil and gas, and construction
  • Public sector organizations, including fire departments, police, and disaster protection agencies
AI Güveni: 71% Güncellendi: 15 Mar 2026

Finansallar

Grafik & Bilgi

Drägerwerk AG & Co. KGaA (DWRKF) hisse senedi fiyatı: Price data unavailable

Son Haberler

DWRKF için son haber bulunmamaktadır.

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

DWRKF için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

DWRKF için Wall Street fiyat hedefi analizi.

MoonshotScore

49/100

Bu puan ne anlama geliyor?

MoonshotScore, DWRKF'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

Yönetim: Stefan A. Drager

Unknown

Information on Stefan A. Drager's specific background, career history, education, and previous roles is not available in the provided data. However, as CEO, he is responsible for managing the overall strategic direction and operations of Drägerwerk AG & Co. KGaA, a company with over 15,000 employees.

Sicil: Due to the limited information available, it is not possible to provide specific details on Stefan A. Drager's key achievements, strategic decisions, or company milestones under his leadership. His role involves overseeing the company's activities in medical and safety technology across multiple global markets.

DWRKF OTC Piyasa Bilgileri

The OTC Other tier represents the lowest tier of the OTC market, indicating that Drägerwerk AG & Co. KGaA may not meet the minimum financial or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting, making it more difficult for investors to assess their financial health and performance. Unlike NYSE or NASDAQ listings, OTC Other stocks often lack stringent listing standards, resulting in increased risks for investors.

  • OTC Katmanı: OTC Other
  • Açıklama Durumu: Unknown
Likidite: As an OTC Other stock, DWRKF likely experiences lower trading volume and wider bid-ask spreads compared to stocks listed on major exchanges. This can make it more challenging for investors to buy or sell shares quickly and at desired prices. The limited liquidity may also increase price volatility, making it essential for investors to exercise caution and use limit orders to manage their risk.
OTC Risk Faktörleri:
  • Limited financial disclosure and transparency.
  • Lower trading volume and liquidity.
  • Wider bid-ask spreads.
  • Increased price volatility.
  • Potential for fraud or manipulation.
Durum Tespiti Kontrol Listesi:
  • Verify the company's financial statements and disclosures.
  • Research the company's management team and their track record.
  • Assess the company's business model and competitive landscape.
  • Review any available analyst reports or independent research.
  • Understand the risks associated with investing in OTC stocks.
  • Consult with a financial advisor before investing.
  • Check for any regulatory actions or legal issues.
Meşruiyet Sinyalleri:
  • The company has been in operation since 1889.
  • Drägerwerk AG & Co. KGaA has a global presence.
  • The company operates in the regulated medical and safety technology sectors.
  • The company has a diverse product portfolio.
  • The company has a large number of employees (15,170).

DWRKF Healthcare Hisse Senedi SSS

DWRKF için değerlendirilmesi gereken temel faktörler nelerdir?

Drägerwerk AG & Co. KGaA (DWRKF) şu anda yapay zeka skoru 49/100, düşük puanı gösteriyor. Temel güçlü yan: Diversified product portfolio across medical and safety technology.. İzlenmesi gereken birincil risk: Potential: Economic downturns affecting healthcare spending.. Bu bir finansal tavsiye değildir.

DWRKF MoonshotScore'u nedir?

DWRKF şu anda MoonshotScore'da 49/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

DWRKF verileri ne sıklıkla güncellenir?

DWRKF fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler DWRKF hakkında ne diyor?

DWRKF için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

DWRKF'a yatırım yapmanın riskleri nelerdir?

DWRKF için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Economic downturns affecting healthcare spending.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

DWRKF'ın P/E oranı nedir?

DWRKF için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için DWRKF'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

DWRKF aşırı değerli mi, yoksa düşük değerli mi?

Drägerwerk AG & Co. KGaA (DWRKF)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

DWRKF'ın temettü verimi nedir?

Drägerwerk AG & Co. KGaA (DWRKF) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Information is based on available data as of 2026-03-15.
  • OTC market data may have limited availability and reliability.
  • AI analysis pending for DWRKF.
Veri Kaynakları

Popüler Hisseler